Q9QXQ0
Gene name |
Actn4 |
Protein name |
Alpha-actinin-4 |
Names |
Non-muscle alpha-actinin 4 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:63836 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
759-911 (EF-hand domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q9QXQ0
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q9QXQ0-F1 | Predicted | AlphaFoldDB |
No variants for Q9QXQ0
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q9QXQ0 |
No associated diseases with Q9QXQ0
12 regional properties for Q9QXQ0
Type | Name | Position | InterPro Accession |
---|---|---|---|
conserved_site | Actinin-type actin-binding domain, conserved site | 52 - 61 | IPR001589-1 |
conserved_site | Actinin-type actin-binding domain, conserved site | 126 - 150 | IPR001589-2 |
domain | Calponin homology domain | 50 - 154 | IPR001715-1 |
domain | Calponin homology domain | 163 - 269 | IPR001715-2 |
repeat | Spectrin repeat | 293 - 402 | IPR002017-1 |
repeat | Spectrin repeat | 413 - 517 | IPR002017-2 |
repeat | Spectrin repeat | 530 - 639 | IPR002017-3 |
repeat | Spectrin repeat | 650 - 751 | IPR002017-4 |
domain | EF-hand domain | 765 - 841 | IPR002048 |
domain | EF-hand, Ca insensitive | 841 - 907 | IPR014837 |
repeat | Spectrin/alpha-actinin | 296 - 754 | IPR018159 |
binding_site | EF-Hand 1, calcium-binding site | 778 - 790 | IPR018247 |
Functions
18 GO annotations of cellular component
Name | Definition |
---|---|
actin cytoskeleton | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. |
cell junction | A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella. |
cell projection | A prolongation or process extending from a cell, e.g. a flagellum or axon. |
cell-cell junction | A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects. |
cortical actin cytoskeleton | The portion of the actin cytoskeleton, comprising filamentous actin and associated proteins, that lies just beneath the plasma membrane. |
cortical cytoskeleton | The portion of the cytoskeleton that lies just beneath the plasma membrane. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
focal adhesion | A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ). |
neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
pseudopodium | A temporary protrusion or retractile process of a cell, associated with flowing movements of the protoplasm, and serving for locomotion and feeding. |
ribonucleoprotein complex | A macromolecular complex that contains both RNA and protein molecules. |
stress fiber | A contractile actin filament bundle that consists of short actin filaments with alternating polarity, cross-linked by alpha-actinin and possibly other actin bundling proteins, and with myosin present in a periodic distribution along the fiber. |
Z disc | Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached. |
14 GO annotations of molecular function
Name | Definition |
---|---|
actin filament binding | Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits. |
calcium ion binding | Binding to a calcium ion (Ca2+). |
chromatin DNA binding | Binding to DNA that is assembled into chromatin. |
nuclear receptor binding | Binding to a nuclear receptor protein. Nuclear receptor proteins are DNA-binding transcription factors which are regulated by binding to a ligand. |
nuclear receptor coactivator activity | A transcription coactivator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound nuclear receptor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. |
nuclear retinoic acid receptor binding | Binding to a nuclear retinoic acid receptor, a ligand-regulated transcription factor belonging to the nuclear receptor superfamily. |
nucleoside binding | Binding to a nucleoside, a compound consisting of a purine or pyrimidine nitrogenous base linked either to ribose or deoxyribose. |
protein homodimerization activity | Binding to an identical protein to form a homodimer. |
protein-containing complex binding | Binding to a macromolecular complex. |
RNA polymerase II transcription regulatory region sequence-specific DNA binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
structural constituent of cytoskeleton | The action of a molecule that contributes to the structural integrity of a cytoskeletal structure. |
transcription coactivator activity | A transcription coregulator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coactivators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. |
transmembrane transporter binding | Binding to a transmembrane transporter, a protein or protein complex that enables the transfer of a substance, usually a specific substance or a group of related substances, from one side of a membrane to the other. |
ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
20 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
actin filament bundle assembly | The assembly of actin filament bundles; actin filaments are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness. |
bicellular tight junction assembly | The aggregation, arrangement and bonding together of a set of components to form a tight junction, an occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet. |
gene expression | The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes. |
glomerulus development | The progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft which forms a close network with the visceral epithelium (podocytes) and the mesangium to form the filtration barrier and is surrounded by Bowman's capsule in nephrons of the vertebrate kidney. The glomerulus is part of the nephron and is restricted to one body segment. |
muscle cell development | The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate. |
negative regulation of substrate adhesion-dependent cell spreading | Any process that stops, prevents or reduces the frequency, rate or extent of substrate adhesion-dependent cell spreading. |
peroxisome proliferator activated receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to any of the peroxisome proliferator activated receptors (alpha, beta or gamma) in the nuclear membrane, and ending with the initiation or termination of the transcription of target genes. |
podocyte cell migration | The orderly movement of a podocyte from one site to another, often during the development of a multicellular organism or multicellular structure. A podocyte is a specialized kidney epithelial cell. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of non-canonical NF-kappaB signal transduction | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
positive regulation of pinocytosis | Any process that activates, maintains or increases the rate of pinocytosis. Pinocytosis is the process in which cells take in liquid material from their external environment; literally 'cell drinking'. Liquid is enclosed in vesicles, formed by invagination of the plasma membrane. These vesicles then move into the cell and pass their contents to endosomes. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
protein localization to bicellular tight junction | A process in which a protein is transported to, or maintained in, a location within a bicellular tight junction. |
protein transport | The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
retinoic acid receptor signaling pathway | The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands. |
tumor necrosis factor-mediated signaling pathway | The series of molecular signals initiated by tumor necrosis factor binding to its receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
vesicle transport along actin filament | Movement of a vesicle along an actin filament, mediated by motor proteins. |
18 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A5D7D1 | ACTN4 | Alpha-actinin-4 | Bos taurus (Bovine) | SS |
Q0III9 | ACTN3 | Alpha-actinin-3 | Bos taurus (Bovine) | SS |
Q3B7N2 | ACTN1 | Alpha-actinin-1 | Bos taurus (Bovine) | SS |
Q3ZC55 | ACTN2 | Alpha-actinin-2 | Bos taurus (Bovine) | SS |
P05094 | ACTN1 | Alpha-actinin-1 | Gallus gallus (Chicken) | SS |
P20111 | ACTN2 | Alpha-actinin-2 | Gallus gallus (Chicken) | SS |
Q90734 | ACTN4 | Alpha-actinin-4 | Gallus gallus (Chicken) | SS |
P18091 | Actn | Alpha-actinin, sarcomeric | Drosophila melanogaster (Fruit fly) | SS |
Q08043 | ACTN3 | Alpha-actinin-3 | Homo sapiens (Human) | SS |
P12814 | ACTN1 | Alpha-actinin-1 | Homo sapiens (Human) | SS |
P35609 | ACTN2 | Alpha-actinin-2 | Homo sapiens (Human) | EV |
O43707 | ACTN4 | Alpha-actinin-4 | Homo sapiens (Human) | SS |
Q9JI91 | Actn2 | Alpha-actinin-2 | Mus musculus (Mouse) | SS |
O88990 | Actn3 | Alpha-actinin-3 | Mus musculus (Mouse) | SS |
P57780 | Actn4 | Alpha-actinin-4 | Mus musculus (Mouse) | SS |
Q7TPR4 | Actn1 | Alpha-actinin-1 | Mus musculus (Mouse) | SS |
Q9Z1P2 | Actn1 | Alpha-actinin-1 | Rattus norvegicus (Rat) | SS |
Q9QWN8 | Sptbn2 | Spectrin beta chain, non-erythrocytic 2 | Rattus norvegicus (Rat) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MVDYHAANQA | YQYGPSSGGN | GTGGGGGMGD | YMAQEDDWDR | DLLLDPAWEK | QQRKTFTAWC |
70 | 80 | 90 | 100 | 110 | 120 |
NSHLRKAGTQ | IENIDEDFRD | GLKLMLLLEV | ISGERLPKPE | RGKMRVHKIN | NVNKALDFIA |
130 | 140 | 150 | 160 | 170 | 180 |
SKGVKLVSIG | AEEIVDGNAK | MTLGMIWTII | LRFAIQDISV | EETSAKEGLL | LWCQRKTAPY |
190 | 200 | 210 | 220 | 230 | 240 |
KNVNVQNFHI | SWKDGLAFNA | LIHRHRPELI | EYDKLRKDDP | VTNLNNAFEV | AEKYLDIPKM |
250 | 260 | 270 | 280 | 290 | 300 |
LDAEDIVNTA | RPDEKAIMTY | VSSFYHAFSG | AQKAETAANR | ICKVLAVNQE | NEHLMEDYER |
310 | 320 | 330 | 340 | 350 | 360 |
LASDLLEWIR | RTIPWLEDRV | PQKTIQEMQQ | KLEDFRDYRR | VHKPPKVQEK | CQLEINFNTL |
370 | 380 | 390 | 400 | 410 | 420 |
QTKLRLSNRP | AFMPSEGRMV | SDINNGWQHL | EQAEKGYEEW | LLNEIRRLER | LDHLAEKFRQ |
430 | 440 | 450 | 460 | 470 | 480 |
KASIHEAWTD | GKEAMLKHRD | YETATLSDIK | ALIRKHEAFE | SDLAAHQDRV | EQIAAIAQEL |
490 | 500 | 510 | 520 | 530 | 540 |
NELDYYDSHN | VNTRCQKICD | QWDNLGSLTH | SRREALEKTE | KQLETIDQLH | LEYAKRAAPF |
550 | 560 | 570 | 580 | 590 | 600 |
NNWMESAMED | LQDMFIVHTI | EEIEGLISAH | DQFKSTLPDA | DREREAILAI | HKEAQRIAES |
610 | 620 | 630 | 640 | 650 | 660 |
NHIKLSGSNP | YTSVTPQIIN | SKWEKVQQLV | PKRDHALLEE | QSKQQSNEHL | RRQFASQANM |
670 | 680 | 690 | 700 | 710 | 720 |
VGPWIQTKME | EIGRISIEMN | GTLEDQLSHL | KQYERSIVDY | KPNLDLLEQQ | HQLIQEALIF |
730 | 740 | 750 | 760 | 770 | 780 |
DNKHTNYTME | HLRVGWEQLL | TTIARTINEV | ENQILTRDAK | GISQEQMQEF | RASFNHFDKD |
790 | 800 | 810 | 820 | 830 | 840 |
HGGALGPEEF | KACLISLGYD | VENDRQGDAE | FNRIMSVVDP | NHSGLVTFQA | FIDFMSRETT |
850 | 860 | 870 | 880 | 890 | 900 |
DTDTADQVIA | SFKVLAGDKN | FITAEELRRE | LPPDQAEYCI | ARMAPYQGPD | AAPGALDYKS |
910 | |||||
FSTALYGESD | L |